Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.

<h4>Background</h4>The stem cell factor receptor, KIT, is a target for the treatment of cancer, mastocytosis, and inflammatory diseases. Here, we characterise the in vitro and in vivo profiles of masitinib (AB1010), a novel phenylaminothiazole-type tyrosine kinase inhibitor that targets...

Full description

Bibliographic Details
Main Authors: Patrice Dubreuil, Sébastien Letard, Marco Ciufolini, Laurent Gros, Martine Humbert, Nathalie Castéran, Laurence Borge, Bérengère Hajem, Anne Lermet, Wolfgang Sippl, Edwige Voisset, Michel Arock, Christian Auclair, Phillip S Leventhal, Colin D Mansfield, Alain Moussy, Olivier Hermine
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-09-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19789626/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19789626/?tool=EBI

Similar Items